Regulatory & Compliance

AI and Staffing Cuts Leave U.S. Vulnerable to Biothreats
Management & Regulatory AI and Staffing Cuts Leave U.S. Vulnerable to Biothreats

The intersection of rapid technological disruption and a purging of the federal workforce has created a policy vacuum that threatens the nation's response to synthetic viruses. Current shifts in the American national security posture indicate a systematic dismantling of the biological defense

Annie Jacobsen’s Biological War Warns of Global Bio-Threats
Management & Regulatory Annie Jacobsen’s Biological War Warns of Global Bio-Threats

The proliferation of over one thousand high-containment laboratories in the United States since 9/11 has paradoxically increased the mathematical probability of a catastrophic accident. This startling statistic serves as the foundation for Annie Jacobsen’s investigation into the burgeoning threat

Can Upadacitinib Redefine the Regulatory Path for Vitiligo?
Research & Development Can Upadacitinib Redefine the Regulatory Path for Vitiligo?

Historical failures in the vitiligo pipeline, such as the cancellation of the AC##4 trial in 2016, highlight the difficulty of establishing a global site network. The recent publication of the Viti-Up Phase 3 clinical trial results in The Lancet marks a transformative moment for dermatologic

Will the FDA Approve Deramiocel for Duchenne Muscular Dystrophy?
Research & Development Will the FDA Approve Deramiocel for Duchenne Muscular Dystrophy?

For the 15,000 Americans living with Duchenne muscular dystrophy, the three-month regulatory delay represents a critical window where irreversible physical decline remains a constant threat. This extension, moving the target decision date from August to November 22, 2026, occurred after the Food

AI Tools Pose National Security Risks in Biotechnology
Tech & Innovation AI Tools Pose National Security Risks in Biotechnology

The RAND Corporation warns that current AI capabilities in applied biological sciences could soon enable the creation of catastrophic health threats. Rapid advancements in Large Language Models (LLMs) and Biological Design Tools (BDTs) have fundamentally altered the landscape of biosecurity. These

VA Tests Semaglutide as a New Treatment for Alcoholism
Research & Development VA Tests Semaglutide as a New Treatment for Alcoholism

VA leadership has issued a cautionary warning against the off-label use of GLP-1 medications for alcoholism without strict medical supervision and oversight. This directive arrives just as the Charles George VA Medical Center in Asheville, North Carolina, spearheads a transformative Phase 3

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later